Concourse Financial Group Securities’s Lyell Immunopharma LYEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Hold |
0
| – | – | – | 4841 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 5847 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 5837 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 5863 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 5868 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 5807 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 5689 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 5568 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 5371 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 5364 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 5181 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 5186 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 5088 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 5112 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 4980 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 4827 |
|